The introduction of nicotinamide like a nicotine replacement in e-cigarette and smokeless products and solutions signifies an important regulatory obstacle for that FDA. Nicotinamide does not have nicotinic receptor agonist activity and is known to work as a sedative at higher dosages6. The statements made by Nicotine River, ECBlend, and other dist